Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

CD176 anticorps

L’anticorps Souris Monoclonal anti-CD176 a été validé pour IHC, IF et StM. Il convient pour détecter CD176 dans des échantillons de Humain, Souris et Rat.
N° du produit ABIN6941356

Aperçu rapide pour CD176 anticorps (ABIN6941356)

Antigène

CD176 (Thomsen Friedenreich Antigen (CD176))

Reactivité

Humain, Souris, Rat

Hôte

  • 4
Souris

Clonalité

  • 4
Monoclonal

Conjugué

  • 4
Cet anticorp CD176 est non-conjugé

Application

  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Immunohistochemistry (IHC), Immunofluorescence (IF), Staining Methods (StM)

Clone

A78-G-A7
  • Specificité

    Recognizes a disaccharide epitope, Gal 1-3GalNAc, of Thomsen-Friedenreich (TF) antigen. It is specific for both anomeric forms of the disaccharide (TF and TF , including related structures on the glycolipid) and shows no cross-reactivity with sialylated glycophorin. The Thomsen-Friedenreich antigen acts as an oncofetal antigen, with low expression in normal adult tissues but increasing to fetal levels of expression in hyperplasia or malignancy. It is considered as a pan-carcinoma marker. This MAb is capable to agglutinate desialylated red blood cells. During metastasis, the ability of malignant cells to form multicellular aggregates via homotypic or heterotypic aggregation and their adhesion to the endothelium are critical. The tumor-associated carbohydrate Thomsen-Friedenreich antigen (Gal-GalNAc) is involved in tumor cell adhesion and tissue invasion. It also causes an immune response, and overexpression of the antigen causes cancer cells to be more sensitive to natural killer cell lysis. The Thomsen-Friedenreich antigen is suppressed in normal healthy cells and represents one of the few chemically well-defined antigens associated with tumor malignancy. The presence of the Thomsen-Friedenreich antigen on the surface of cancer cells may result from a divergence from the normal pathway for O-linked glycosylation in these cells, most likely caused by inappropriate localization of the enzymes involved in synthesis of the disaccharide.

    Immunogène

    Neuraminidase-treated human red blood cells

    Isotype

    IgM kappa
  • Indications d'application

    Positive Control: KG1 cells. Human colorectal carcinoma tissues.

    Known Application: Immunofluorescence (0.5-1 μg/mL), Immunohistochemistry (Formalin-fixed) (0.5-1.0 μg/mL for 30 minutes at RT)(Staining of formalin-fixed tissues requires boiling tissue sections in 10 mM citrate buffer, pH 6.0, for 10-20 min followed by cooling at RT for 20 minutes)Optimal dilution for a specific application should be determined.

    Restrictions

    For Research Use only
  • Concentration

    200 μg/mL

    Buffer

    10 mM PBS with 0.05 % BSA & 0.05 % azide.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C,-80 °C

    Stockage commentaire

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

    Date de péremption

    24 months
  • Antigène

    CD176 (Thomsen Friedenreich Antigen (CD176))

    Autre désignation

    Thomsen-Friedenreich Antigen / CD176 (Pan Carcinoma Marker)
Vous êtes ici:
Chat with us!